ClinVar Miner

Submissions for variant NM_002230.4(JUP):c.490A>G (p.Met164Val)

gnomAD frequency: 0.00003  dbSNP: rs782573703
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000220556 SCV000279811 uncertain significance not provided 2016-01-25 criteria provided, single submitter clinical testing The M164V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at aposition that is conserved in mammals. However, Valine is the wild-type amino acid at this position in as least twospecies. In addition, the M164V variant is a conservative amino acid substitution, which is not likely to impactsecondary protein structure as these residues share similar properties. In silico analysis is inconsistent in itspredictions as to whether or not the variant is damaging to the protein structure/function. Furthermore, no pathogenicmissense variants in nearby residues have been reported in the Human Gene Mutation Database (Stenson et al., 2014). Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.